HVNI Ambulation Feasibility Study

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 21, 2018

Primary Completion Date

February 28, 2019

Study Completion Date

March 11, 2019

Conditions
Respiratory InsufficiencyDyspnea
Interventions
DEVICE

Precision Flow Plus

High velocity nasal insufflation

DEVICE

Treatment as Usual

Conventional therapy per institution

Trial Locations (3)

23601

Riverside Regional Medical Center, Newport News

43050

Knox Community Hospital, Mount Vernon

63301

Midwest Chest Consultants, Saint Charles

All Listed Sponsors
collaborator

Knox Community Hospital

OTHER

collaborator

Riverside Medical Center

OTHER

collaborator

Midwest Chest Consultants

OTHER

lead

Vapotherm, Inc.

INDUSTRY

NCT03885726 - HVNI Ambulation Feasibility Study | Biotech Hunter | Biotech Hunter